| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 8 |
| NetGPI | no | yes: 0, no: 8 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 4 |
| GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4HTT7
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.342 |
| CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.428 |
| CLV_PCSK_FUR_1 | 33 | 37 | PF00082 | 0.336 |
| CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.327 |
| DEG_SPOP_SBC_1 | 103 | 107 | PF00917 | 0.394 |
| DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.395 |
| DOC_USP7_MATH_1 | 108 | 112 | PF00917 | 0.384 |
| DOC_WW_Pin1_4 | 104 | 109 | PF00397 | 0.475 |
| DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.518 |
| DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.497 |
| LIG_14-3-3_CanoR_1 | 92 | 101 | PF00244 | 0.391 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.640 |
| LIG_BRCT_BRCA1_1 | 1 | 5 | PF00533 | 0.558 |
| LIG_EH1_1 | 43 | 51 | PF00400 | 0.194 |
| LIG_FHA_1 | 12 | 18 | PF00498 | 0.567 |
| LIG_FHA_2 | 93 | 99 | PF00498 | 0.412 |
| LIG_LIR_Nem_3 | 60 | 66 | PF02991 | 0.406 |
| LIG_LIR_Nem_3 | 76 | 82 | PF02991 | 0.382 |
| LIG_NRBOX | 16 | 22 | PF00104 | 0.514 |
| LIG_PTB_Apo_2 | 53 | 60 | PF02174 | 0.321 |
| LIG_PTB_Phospho_1 | 53 | 59 | PF10480 | 0.321 |
| LIG_SH2_CRK | 63 | 67 | PF00017 | 0.287 |
| LIG_SH2_STAP1 | 59 | 63 | PF00017 | 0.292 |
| LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.558 |
| LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.274 |
| LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.253 |
| LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.407 |
| LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.390 |
| LIG_SH3_3 | 23 | 29 | PF00018 | 0.506 |
| LIG_TRFH_1 | 19 | 23 | PF08558 | 0.564 |
| MOD_CDC14_SPxK_1 | 107 | 110 | PF00782 | 0.387 |
| MOD_CDC14_SPxK_1 | 22 | 25 | PF00782 | 0.506 |
| MOD_CDK_SPxK_1 | 104 | 110 | PF00069 | 0.387 |
| MOD_CDK_SPxK_1 | 19 | 25 | PF00069 | 0.511 |
| MOD_CK2_1 | 25 | 31 | PF00069 | 0.576 |
| MOD_CK2_1 | 92 | 98 | PF00069 | 0.410 |
| MOD_Cter_Amidation | 6 | 9 | PF01082 | 0.335 |
| MOD_DYRK1A_RPxSP_1 | 25 | 29 | PF00069 | 0.534 |
| MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.607 |
| MOD_GSK3_1 | 104 | 111 | PF00069 | 0.397 |
| MOD_GSK3_1 | 21 | 28 | PF00069 | 0.522 |
| MOD_GSK3_1 | 57 | 64 | PF00069 | 0.298 |
| MOD_GSK3_1 | 81 | 88 | PF00069 | 0.408 |
| MOD_NEK2_1 | 109 | 114 | PF00069 | 0.397 |
| MOD_NEK2_1 | 74 | 79 | PF00069 | 0.381 |
| MOD_PKA_2 | 109 | 115 | PF00069 | 0.376 |
| MOD_PKA_2 | 12 | 18 | PF00069 | 0.520 |
| MOD_PKA_2 | 91 | 97 | PF00069 | 0.396 |
| MOD_Plk_1 | 57 | 63 | PF00069 | 0.297 |
| MOD_Plk_4 | 74 | 80 | PF00069 | 0.394 |
| MOD_ProDKin_1 | 104 | 110 | PF00069 | 0.477 |
| MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.511 |
| TRG_ENDOCYTIC_2 | 63 | 66 | PF00928 | 0.372 |
| TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.317 |
| TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.517 |
| TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.313 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5B9 | Leptomonas seymouri | 61% | 100% |
| A0A3S7WQJ7 | Leishmania donovani | 98% | 100% |
| A4H5J4 | Leishmania braziliensis | 75% | 100% |
| D0A994 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
| E9AML8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
| Q4QI07 | Leishmania major | 88% | 100% |
| V5BIJ0 | Trypanosoma cruzi | 45% | 100% |